Seagen (NASDAQ:SGEN) Coverage Initiated at started coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Several other research analysts have also recently commented on the stock. Morgan Stanley restated an equal weight rating and issued a $229.00 target price on shares of […]

Leave a Reply

Your email address will not be published.

Previous post NextGen Healthcare (NASDAQ:NXGN) Receives New Coverage from Analysts at
Next post St. John’s Prep-Xaverian with rare doubleheader